Skip to main content

Diffuse Mesothelioma Payment Scheme

Volume 619: debated on Wednesday 18 January 2017

The Diffuse Mesothelioma Payment Scheme (Levy) regulations 2014 require active employers’ liability insurers to pay an annual levy based on their relative market share for the purpose of meeting the costs of the Diffuse Mesothelioma Payment Scheme (DMPS). This is in line with the commitment by the insurance industry to fund a scheme of last resort for sufferers of diffuse mesothelioma who have been unable to trace their employer or their employer’s insurer.

I can announce today that the total amount of the levy to be charged for 2016-17, the third year of the DMPS, is £40.4 million. This includes £5.2 million to accommodate a levy shortfall last year. The amount will be payable by active insurers by the end of March 2017.

Individual active insurers will be notified in writing of their payment amount (i.e. their share of the levy), together with how the amount was calculated and payment arrangements. Insurers should be aware that it is a legal requirement to pay the levy within the set timescales.

I am pleased that the DMPS has seen two successful years of operation, assisting many sufferers of diffuse mesothelioma. The second annual report for the scheme was published on 29 November 2016 and is available on the website. I hope that members of both Houses will welcome this announcement and give the DMPS their continued support.